133 related articles for article (PubMed ID: 15814571)
21. Induction of hepatic multidrug resistance-associated protein 3 by ethynylestradiol is independent of cholestasis and mediated by estrogen receptor.
Ruiz ML; Rigalli JP; Arias A; Villanueva S; Banchio C; Vore M; Mottino AD; Catania VA
Drug Metab Dispos; 2013 Feb; 41(2):275-80. PubMed ID: 23077105
[TBL] [Abstract][Full Text] [Related]
22. Multidrug Resistance-Associated Protein 3 Is Responsible for the Efflux Transport of Curcumin Glucuronide from Hepatocytes to the Blood.
Jia YM; Zhu T; Zhou H; Ji JZ; Tai T; Xie HG
Drug Metab Dispos; 2020 Oct; 48(10):966-971. PubMed ID: 31900255
[TBL] [Abstract][Full Text] [Related]
23. Characterization of drug transport by the human multidrug resistance protein 3 (ABCC3).
Zelcer N; Saeki T; Reid G; Beijnen JH; Borst P
J Biol Chem; 2001 Dec; 276(49):46400-7. PubMed ID: 11581266
[TBL] [Abstract][Full Text] [Related]
24. Oleanolic acid attenuates obstructive cholestasis in bile duct-ligated mice, possibly via activation of NRF2-MRPs and FXR antagonism.
Chen P; Li J; Fan X; Zeng H; Deng R; Li D; Huang M; Bi H
Eur J Pharmacol; 2015 Oct; 765():131-9. PubMed ID: 26297978
[TBL] [Abstract][Full Text] [Related]
25. Altered disposition of acetaminophen in mice with a disruption of the Mrp3 gene.
Manautou JE; de Waart DR; Kunne C; Zelcer N; Goedken M; Borst P; Elferink RO
Hepatology; 2005 Nov; 42(5):1091-8. PubMed ID: 16250050
[TBL] [Abstract][Full Text] [Related]
26. Induction of multidrug resistance protein 3 (mrp3) in vivo is independent of constitutive androstane receptor.
Cherrington NJ; Slitt AL; Maher JM; Zhang XX; Zhang J; Huang W; Wan YJ; Moore DD; Klaassen CD
Drug Metab Dispos; 2003 Nov; 31(11):1315-9. PubMed ID: 14570762
[TBL] [Abstract][Full Text] [Related]
27. Carcinogen and anticancer drug transport by Mrp2 in vivo: studies using Mrp2 (Abcc2) knockout mice.
Vlaming ML; Mohrmann K; Wagenaar E; de Waart DR; Elferink RP; Lagas JS; van Tellingen O; Vainchtein LD; Rosing H; Beijnen JH; Schellens JH; Schinkel AH
J Pharmacol Exp Ther; 2006 Jul; 318(1):319-27. PubMed ID: 16611851
[TBL] [Abstract][Full Text] [Related]
28. Identification and functional characterization of the natural variant MRP3-Arg1297His of human multidrug resistance protein 3 (MRP3/ABCC3).
Lee YM; Cui Y; König J; Risch A; Jäger B; Drings P; Bartsch H; Keppler D; Nies AT
Pharmacogenetics; 2004 Apr; 14(4):213-23. PubMed ID: 15083066
[TBL] [Abstract][Full Text] [Related]
29. Cholestasis and the role of basolateral efflux pumps.
Keppler D
Z Gastroenterol; 2011 Jul; 49(12):1553-7. PubMed ID: 22139880
[TBL] [Abstract][Full Text] [Related]
30. Impact of Abcc2 (Mrp2) and Abcc3 (Mrp3) on the in vivo elimination of methotrexate and its main toxic metabolite 7-hydroxymethotrexate.
Vlaming ML; Pala Z; van Esch A; Wagenaar E; van Tellingen O; de Waart DR; Oude Elferink RP; van de Wetering K; Schinkel AH
Clin Cancer Res; 2008 Dec; 14(24):8152-60. PubMed ID: 19088030
[TBL] [Abstract][Full Text] [Related]
31. Tissue distribution and induction of human multidrug resistant protein 3.
Scheffer GL; Kool M; de Haas M; de Vree JM; Pijnenborg AC; Bosman DK; Elferink RP; van der Valk P; Borst P; Scheper RJ
Lab Invest; 2002 Feb; 82(2):193-201. PubMed ID: 11850532
[TBL] [Abstract][Full Text] [Related]
32. Bile salt transporters.
Meier PJ; Stieger B
Annu Rev Physiol; 2002; 64():635-61. PubMed ID: 11826283
[TBL] [Abstract][Full Text] [Related]
33. CAR and PXR agonists stimulate hepatic bile acid and bilirubin detoxification and elimination pathways in mice.
Wagner M; Halilbasic E; Marschall HU; Zollner G; Fickert P; Langner C; Zatloukal K; Denk H; Trauner M
Hepatology; 2005 Aug; 42(2):420-30. PubMed ID: 15986414
[TBL] [Abstract][Full Text] [Related]
34. Effect of bile acids on the expression of MRP3 and MRP4: An In vitro study in HepG2 cell line.
Pérez-Pineda SI; Baylón-Pacheco L; Espíritu-Gordillo P; Tsutsumi V; Rosales-Encina JL
Ann Hepatol; 2021; 24():100325. PubMed ID: 33582321
[TBL] [Abstract][Full Text] [Related]
35. p53-mediated regulation of bile acid disposition attenuates cholic acid-induced cholestasis in mice.
Chen P; Li D; Chen Y; Sun J; Fu K; Guan L; Zhang H; Jiang Y; Li X; Zeng X; Chen X; Huang M; Bi H
Br J Pharmacol; 2017 Dec; 174(23):4345-4361. PubMed ID: 28910492
[TBL] [Abstract][Full Text] [Related]
36. Partial characterization of cytoprotective mechanisms of lecithin against bile salt-induced bile duct damage.
Tsuboi K; Tazuma S; Nishioka T; Chayama K
J Gastroenterol; 2004 Oct; 39(10):955-60. PubMed ID: 15549448
[TBL] [Abstract][Full Text] [Related]
37. Serotonin protects mouse liver from cholestatic injury by decreasing bile salt pool after bile duct ligation.
Jang JH; Rickenbacher A; Humar B; Weber A; Raptis DA; Lehmann K; Stieger B; Moritz W; Soll C; Georgiev P; Fischer D; Laczko E; Graf R; Clavien PA
Hepatology; 2012 Jul; 56(1):209-18. PubMed ID: 22290718
[TBL] [Abstract][Full Text] [Related]
38. Nuclear receptors RXRalpha:RARalpha are repressors for human MRP3 expression.
Chen W; Cai SY; Xu S; Denson LA; Soroka CJ; Boyer JL
Am J Physiol Gastrointest Liver Physiol; 2007 May; 292(5):G1221-7. PubMed ID: 17272513
[TBL] [Abstract][Full Text] [Related]
39. Modulation of multidrug resistance-associated protein 2 (Mrp2) and Mrp3 expression and function with small interfering RNA in sandwich-cultured rat hepatocytes.
Tian X; Zamek-Gliszczynski MJ; Zhang P; Brouwer KL
Mol Pharmacol; 2004 Oct; 66(4):1004-10. PubMed ID: 15385645
[TBL] [Abstract][Full Text] [Related]
40. Benefit of farnesoid X receptor inhibition in obstructive cholestasis.
Stedman C; Liddle C; Coulter S; Sonoda J; Alvarez JG; Evans RM; Downes M
Proc Natl Acad Sci U S A; 2006 Jul; 103(30):11323-8. PubMed ID: 16844773
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
